Quadrant Capital Management, LLC Buys Bristol-Myers Squibb Company, Cummins Inc, Vanguard Mid-Cap Value, Sells GlaxoSmithKline PLC

• New Purchases: BMY, CMI, VOE, CSCO, SCHW, SCHX, WLTW,
• Added Positions: EFV, SCHF, VNQ, AAPL, XOM, VSS, IWD, O, MAA, SPG, IWF, CLDT, VZ, ACN, ORCL, ARE, JPM, BXP, ESS, CUBE, DLR, EXR, FR, EFA, STAG, WM, SPY, VB, XLV, IVV,
• Reduced Positions: XLY, BDX, XLF, CHKP, EEM, GILD, IWN,
• Sold Out: GSK,

For the details of Quadrant Capital Management, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/quadrant+capital+management%2C+llc/current-portfolio/portfolio

1. Schwab International Equity (SCHF) - 293,844 shares, 5.27% of the total portfolio. Shares added by 4.11%
2. Apple Inc (AAPL) - 29,783 shares, 3.24% of the total portfolio. Shares added by 2.75%
3. Vanguard FTSE All-Wld ex-US SmCp Idx (VSS) - 51,835 shares, 3.09% of the total portfolio. Shares added by 2.53%
4. Vanguard Small-Cap Value (VBR) - 37,165 shares, 2.74% of the total portfolio.
5. SPDR Select Sector Fund - Consumer Discretionary (XLY) - 41,780 shares, 2.72% of the total portfolio. Shares reduced by 1.39%

Quadrant Capital Management, LLC initiated holding in Cummins Inc. The purchase prices were between $130.74 and $160.55, with an estimated average price of $149.86. The stock is now traded at around $165.39. The impact to a portfolio due to this purchase was 0.74%. The holding were 8,175 shares as of .

Quadrant Capital Management, LLC initiated holding in Bristol-Myers Squibb Company. The purchase prices were between $45.12 and $53.8, with an estimated average price of $49.88. The stock is now traded at around $47.01. The impact to a portfolio due to this purchase was 0.74%. The holding were 27,150 shares as of .

Quadrant Capital Management, LLC initiated holding in Vanguard Mid-Cap Value. The purchase prices were between $93.87 and $109.02, with an estimated average price of $104.86. The stock is now traded at around $109.65. The impact to a portfolio due to this purchase was 0.45%. The holding were 7,330 shares as of .

Quadrant Capital Management, LLC initiated holding in Cisco Systems Inc. The purchase prices were between $41.07 and $53.99, with an estimated average price of $48.46. The stock is now traded at around $53.36. The impact to a portfolio due to this purchase was 0.19%. The holding were 6,285 shares as of .

Quadrant Capital Management, LLC initiated holding in Charles Schwab Corp. The purchase prices were between $40.72 and $47.98, with an estimated average price of $45.15. The stock is now traded at around $45.86. The impact to a portfolio due to this purchase was 0.17%. The holding were 7,015 shares as of .

Quadrant Capital Management, LLC initiated holding in Schwab U.S. Large-Cap. The purchase prices were between $58.26 and $68.11, with an estimated average price of $64.92. The stock is now traded at around $68.89. The impact to a portfolio due to this purchase was 0.14%. The holding were 3,570 shares as of .

Quadrant Capital Management, LLC added to a holding in iShares MSCI EAFE Value by 112.51%. The purchase prices were between $44.87 and $49.81, with an estimated average price of $48.12. The stock is now traded at around $48.76. The impact to a portfolio due to this purchase was 0.3%. The holding were 20,135 shares as of .

Quadrant Capital Management, LLC added to a holding in Vanguard Real Estate by 56.51%. The purchase prices were between $72.95 and $87.02, with an estimated average price of $82.48. The stock is now traded at around $86.86. The impact to a portfolio due to this purchase was 0.13%. The holding were 7,270 shares as of .

Quadrant Capital Management, LLC added to a holding in Exxon Mobil Corp by 31.72%. The purchase prices were between $68.19 and $81.79, with an estimated average price of $76.09. The stock is now traded at around $76.56. The impact to a portfolio due to this purchase was 0.08%. The holding were 7,425 shares as of .

Quadrant Capital Management, LLC added to a holding in Verizon Communications Inc by 22.77%. The purchase prices were between $53.28 and $60.88, with an estimated average price of $56.61. The stock is now traded at around $56.94. The impact to a portfolio due to this purchase was 0.03%. The holding were 4,782 shares as of .

Quadrant Capital Management, LLC sold out a holding in GlaxoSmithKline PLC. The sale prices were between $37.83 and $41.87, with an estimated average price of $39.95.